🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Universus Photo Imagings Limited UNIVPHOTO NSEPHARMA

Healthcare · Medical Devices · India
https://www.universusphotoimagings.com
Company Profile ↓
₹480.00
+84.05% 1Y
Mkt Cap₹525.44 Cr
P/E-6.57
P/B0.65
52W High₹515.80
52W Low₹188.53
Book Value₹740.45
EPS (TTM)₹-73.02

Company Overview

Universus Photo Imagings Limited manufactures, trades, and sells photographic and other imaging products. The company also manufactures, sells, distributes, converts, and produces X-ray films; and NTR films are used for photo albums, certificates, playing cards, gift cards, visiting cards, calendars, menu cards, wedding invitations, and a modelling portfolio. The company was formerly known as Jindal Photo Imaging Limited and changed its name to Universus Photo Imagings Limited in December 2019. Universus Photo Imagings Limited was incorporated in 2011 and is based in Gurugram, India.

Why Investors Should Care

Positive Free Cash Flow

Generates positive free cash flow, funding growth and shareholder returns internally.

Recent Developments

  • Mar 2026 Revenue of ₹18.78 Cr (-23.7% YoY); net profit ₹-79.94 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +3.9%, earnings -191.9%.
  • 5-Year Trend Long-term compounding — revenue CAGR -24.3%, profit CAGR -26.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:-24.25%
1 Year:3.90%

Compounded Profit Growth

5 Years:-26.59%
1 Year:-191.86%

Stock Price Performance

1 Year:+84.05%
6 Months:+152.47%
3 Months:-0.04%
1 Month:+37.93%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 89% of range
₹188.53 ₹515.80
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • RSI (14)68.99 · Neutral
Price Performance
1M+37.93%
3M-0.04%
6M+152.47%
1Y+84.05%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Generates positive free cash flow.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

  • Revenue declined at -24.3% CAGR over 5 years.
  • Earnings shrank at -26.6% CAGR over 5 years.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-6.57
Industry PE
35.94
Forward P/E
-
PEG Ratio
-
Book Value
₹740.45
Price to Book
0.65
P/S
27.92
EV/EBITDA
-868.54
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
-24.25%
Profit 5Y
-26.59%
Revenue (YoY)
3.90%
Earnings (YoY)
-191.86%

Profitability & Returns

ROCE
-9.55%
ROE
-9.49%
ROA
-0.03%
Profit Margin
0.00%
Op Margin
3.23%
Gross Margin
32.75%
EPS (Latest Qtr)
₹-11.93
EPS (TTM)
₹-73.02

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
257.73
Current Ratio
260.83
Debt
₹0
Total Assets
₹824.99 Cr
Current Assets
₹276.48 Cr
Working Capital
₹275.42 Cr

Ownership

Promoter Holding
89.72%
Chg in Prom Hold
-
FII / Inst Holding
0.27%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹525.44 Cr
Total Revenue (TTM)
₹18.78 Cr
EBITDA
₹-29.00 L
Free Cash Flow
₹4.63 Cr
Operating Cash Flow
₹2.05 Cr
Shares Outstanding
₹1.09 Cr
Gross Margin
32.75%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 UNIVPHOTO Universus Photo Imagings Limited NSEPHARMA 480.00 -6.57 ₹525.44 Cr 0.00% -9.55% -9.49% -24.25% -26.59%
2 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,974.50 66.71 ₹1.29 L Cr 0.22% 19.79% 21.50% 15.33% 33.34%
3 ALKEM Alkem Laboratories Limited NIFTY_MIDNSEPHARMA 5,597.50 29.07 ₹66,926.51 Cr 0.35% 18.56% 17.56% 8.30% 32.74%
4 ABBOTINDIA Abbott India Limited NIFTY_MIDNSEPHARMA 27,855.00 38.12 ₹59,189.93 Cr 1.89% 41.87% 34.46% 9.01% 17.80%
5 ANTHEM ANTHEM BIOSCIENCES LTD NIFTY_MIDNSEPHARMA 825.65 81.26 ₹46,377.90 Cr 0.24% 26.77% 19.45% 26.20% 15.39%
6 AJANTPHARM Ajanta Pharma Limited NIFTY_MIDNSEPHARMA 3,470.40 38.28 ₹43,357.66 Cr 1.86% 29.41% 23.33% 13.40% 21.55%
7 AGARWALEYE DR AGARWALS HEALTH CARE L NSEPHARMA 532.30 127.96 ₹16,875.30 Cr 0.00% 9.74% 6.58% 26.96% 12.28%
8 APLLTD Alembic Pharmaceuticals Limited NSEPHARMA 834.45 23.67 ₹16,402.21 Cr 1.49% 12.77% 12.36% 9.46% 25.42%
9 ALIVUS Alivus Life Sciences Limited NSEPHARMA 1,325.20 27.06 ₹16,265.43 Cr 0.38% 21.78% 16.94% 7.61% 6.53%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 4.47 Cr4.97 Cr5.33 Cr3.84 Cr4.64 Cr
Cost of Revenue 2.98 Cr3.29 Cr3.67 Cr2.40 Cr3.28 Cr
Gross Profit 1.49 Cr1.68 Cr1.66 Cr1.44 Cr1.36 Cr
Operating Expenses 2.77 Cr2.25 Cr1.74 Cr1.36 Cr1.21 Cr
Operating Income -1.28 Cr-57.00 L-8.00 L8.00 L15.00 L
EBITDA -18.72 Cr-15.45 Cr-27.77 Cr-22.57 Cr-12.76 Cr
Interest Expense 00000
Pretax Income -18.75 Cr-15.48 Cr-27.80 Cr-22.60 Cr-12.79 Cr
Tax Provision 2.29 Cr1.54 Cr-1.84 Cr1.29 Cr28.00 L
Net Income -21.04 Cr-17.02 Cr-25.96 Cr-23.89 Cr-13.07 Cr
Diluted EPS -19.23-15.55-23.71-21.83-11.93

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -43.21 Cr32.44 Cr24.60 Cr18.78 Cr
Cost of Revenue -29.72 Cr23.13 Cr17.38 Cr12.63 Cr
Gross Profit -13.49 Cr9.31 Cr7.22 Cr6.15 Cr
Operating Expenses -6.05 Cr5.99 Cr9.10 Cr6.56 Cr
Operating Income -7.44 Cr3.32 Cr-1.88 Cr-41.00 L
EBITDA --39.24 Cr-186.75 Cr95.75 Cr-78.55 Cr
Interest Expense -01,00000
Pretax Income --39.51 Cr-186.97 Cr95.62 Cr-78.67 Cr
Tax Provision -4.96 Cr9.38 Cr8.60 Cr1.27 Cr
Net Income --44.47 Cr-196.35 Cr87.02 Cr-79.94 Cr
Diluted EPS --40.62-179.3779.49-73.02

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -1,058.05 Cr879.67 Cr892.32 Cr824.99 Cr
Current Assets -590.80 Cr627.95 Cr386.44 Cr276.48 Cr
Cash & Equivalents -12.74 L1.39 Cr12.90 L13.00 L
Inventory -12.14 Cr6.74 Cr5.75 Cr1.91 Cr
Receivables -1.52 Cr2.11 Cr1.20 Cr35.00 L
Total Liabilities -10.07 Cr16.09 Cr18.10 Cr13.78 Cr
Current Liabilities -2.33 Cr1.67 Cr2.14 Cr1.06 Cr
Long Term Debt -----
Total Debt -----
Total Equity -1,047.98 Cr863.59 Cr874.22 Cr811.21 Cr
Shares Outstanding -1.09 Cr1.09 Cr1.09 Cr1.09 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow --8.32 Cr3.91 Cr184.71 Cr2.05 Cr
Investing Cash Flow -19.11 Cr-2.65 Cr-185.97 Cr-2.05 Cr
Financing Cash Flow --10.95 Cr-1,00000
Capital Expenditure -2.95 L-1.63 L-58,000-1.00 L-
Free Cash Flow --8.34 Cr3.91 Cr184.70 Cr2.05 Cr
Net Change in Cash --15.86 L1.26 Cr-1.26 Cr0

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -31.2%28.7%29.3%32.7%
Operating Margin % -17.2%10.2%-7.6%-2.2%
Net Margin % --102.9%-605.3%353.7%-425.7%
ROE % --4.2%-22.7%10.0%-9.9%
ROCE % -0.7%0.4%-0.2%-0.0%

Shareholding Pattern

Insiders
89.72%
Institutions
0.27%
Public Float
2.64%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for UNIVPHOTO

No recent headlines available.

UNIVPHOTO — Frequently Asked Questions

What is the current share price of Universus Photo Imagings Limited (UNIVPHOTO)?

As of 2026-08-07 06:31 IST, Universus Photo Imagings Limited (UNIVPHOTO) trades at ₹480.00 on NSE. Its 52-week range is ₹188.53 to ₹515.80.

What is the market capitalisation of UNIVPHOTO?

Universus Photo Imagings Limited (UNIVPHOTO) has a market capitalisation of ₹525.44 Cr on NSE.

What is the P/E ratio of UNIVPHOTO?

UNIVPHOTO trades at a trailing price-to-earnings (P/E) ratio of -6.57. The industry average P/E is 35.94. Its price-to-book (P/B) ratio is 0.65.

What is the return on equity (ROE) of UNIVPHOTO?

UNIVPHOTO has a return on equity (ROE) of -9.49%. Its return on capital employed (ROCE) is -9.55%.

Is UNIVPHOTO a good stock to buy?

This page provides a data-driven analysis of Universus Photo Imagings Limited (UNIVPHOTO), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space